JULIE HUTCHISON: Open Payments
NPI 1649571076 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 92 payments from 16 companies in 2025. Trend: 2023 $1,228 · 2024 $1,468 · 2025 $1,513
Food & beverage: $1,323Education: $189
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $280 |
| OPKO Pharmaceuticals, LLC | 21 | $189 |
| Travere Therapeutics, Inc. | 7 | $183 |
| Fresenius USA Marketing, Inc. | 14 | $149 |
| Ardelyx, Inc. | 8 | $146 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Vifor Pharma, Inc. | 4 | $72 |
| Lilly USA, LLC | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
Products named: KRYSTEXXA, RAYALDEE, VELPHORO, IBSRELA, Fabhalta, TAVNEOS, JYNARQUE, Veltassa.
Industry payments across KY — which companies pay providers there.
